Mr. Chang Wang, The Second Hospital & Clinical Medical School, Lanzhou University, China
Mr. Chang Wang is a dedicated Pharmacist In-Charge at Lanzhou University’s Second Hospital. He holds a Doctor of Medicine candidacy in Traditional Chinese Pharmacy from Gansu University of Chinese Medicine. His expertise spans therapeutic drug monitoring and clinical pharmacology, with significant contributions in drug interactions and high-altitude pharmacology. Mr. Wang has published widely, including in the Journal of Chromatography B and Journal of Mass Spectrometry. He has received the First Prize for Military Scientific and Technological Progress and is an active member of several professional societies, including the International Association of Therapeutic Drug Monitoring. 💊📚
Publication Profile
Scopus
Educational Background 🎓
Mr. Chang Wang is currently pursuing a Doctor of Medicine in Traditional Chinese Pharmacy at Gansu University of Chinese Medicine (2024-present). He earned his Master of Pharmacy from Lanzhou University, School of Pharmacy (2012-2015), where he deepened his expertise in pharmaceutical sciences. Prior to that, he completed his Bachelor of Science in Pharmacy at Lanzhou University, School of Pharmacy (2008-2012). Mr. Wang’s solid educational foundation has enabled him to advance his career as a clinical pharmacist and contribute significantly to the field of therapeutic drug monitoring and clinical pharmacology. 💊📚
Academic Positions 🏥
Mr. Chang Wang currently serves as the Pharmacist In-Charge at the Department of Pharmacy in the Second Hospital & Clinical Medical School, Lanzhou University (2019-present), where he plays a key role in clinical pharmacy operations. Prior to this, he worked as a Pharmacist at the Department of Pharmacy, 940 Hospital, Joint Service Support Force of the Chinese People’s Liberation Army (2015-2018). His extensive experience in both academic and military healthcare settings has strengthened his expertise in pharmacology, therapeutic drug monitoring, and clinical pharmacy practice. 💉💊
Research Focus
Mr. Chang Wang’s research primarily revolves around pharmacology, drug monitoring, and pharmacokinetics. His work includes developing advanced analytical methods, such as UPLC–MS/MS for quantifying drugs like polymyxins and caspofungin for therapeutic drug monitoring. He has contributed significantly to understanding the regulation mechanisms of drug-metabolizing enzymes and transporters, especially in hypoxia and high-altitude environments. His studies also explore the impact of intestinal microflora on drug metabolism, renal excretion, and drug efficacy under varying physiological conditions. Mr. Wang’s research is pivotal in advancing personalized medicine and drug therapy. 💉🧬
Publication Top Notes
- Development and validation of a UPLC–MS/MS method for simultaneous quantification of polymyxins and caspofungin in human plasma for therapeutic drug monitoring – Wu, T., Pu, L., Liu, W., Wang, C., Qiu, W. (2025) 📅
- Modulation of drug-metabolizing enzymes and transporters under hypoxia environment – Min, Q., Feng, S.-L., Lu, H., Wang, R., Zhang, J.-H., Wang, C. (2019) – Cited by 3 📖
- Effects of intestinal microflora on drug metabolism – Chen, Y.-Y., Wang, R., Zhang, J.-H., Wang, C., Sun, Y.-M. (2019) – Cited by 5 💊
- Potential regulation mechanisms of P-gp in the blood-brain barrier in hypoxia – Ding, Y., Wang, R., Zhang, J., Wang, C., Yuan, X. (2019) – Cited by 15 🧠
- Plasma proteomic study of acute mountain sickness susceptible and resistant individuals – Lu, H., Wang, R., Li, W., Sun, Y., Jia, Z. (2018) – Cited by 19 ⛰️
- Research progress of long chain non-coding RNA H19 in anoxic environment mechanism – Yue, X., Wang, R., Li, W., Lu, H., Zhang, J. (2018) – Cited by 1 🧬
- Interaction of amoxicillin and nifedipine mediated by intestinal flora – Zhang, J.-H., Zhang, J.-M., Wang, R., Zhao, A.-P., Jia, Z.-P. (2018) – Cited by 5 💊
- Research progress on clinical gene polymorphism of clopidogrel resistance – Sun, Y.-M., Cui, M.-X., Li, W.-B., Wang, C., Wang, R. (2018) – Cited by 3 🧬
- Evaluation of renal excretion and pharmacokinetics of furosemide in rats after acute exposure to high altitude at 4300 m – Luo, B., Li, J., Yang, T., Zhao, A., Wang, R. (2018) – Cited by 11 🌄
- Advances of studies on effect of drug transporter under hypoxia – Zhang, M.-X., Wang, R., Xu, W.-B., Liu, J.-J., Jia, Z.-P. (2018) – Cited by 5 💉